Nuo Therapeutics, Inc.
AURX
$2.26
$0.010.29%
OTC PK
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 47.40% | 44.55% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 47.40% | 44.55% | |||
| Cost of Revenue | 155.14% | 31.74% | |||
| Gross Profit | 15.62% | 48.84% | |||
| SG&A Expenses | -2.30% | 7.61% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 16.27% | 9.98% | |||
| Operating Income | 17.16% | 12.49% | |||
| Income Before Tax | 17.21% | 12.92% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 17.21% | 12.92% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 17.21% | 12.92% | |||
| EBIT | 17.16% | 12.49% | |||
| EBITDA | 17.81% | 13.81% | |||
| EPS Basic | 18.71% | 12.58% | |||
| Normalized Basic EPS | 18.39% | 13.00% | |||
| EPS Diluted | 18.71% | 12.58% | |||
| Normalized Diluted EPS | 18.39% | 13.00% | |||
| Average Basic Shares Outstanding | 1.53% | 0.01% | |||
| Average Diluted Shares Outstanding | 1.53% | 0.01% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||